Drug Shortage Report for OCTREOSCAN
Report ID | 222588 |
Drug Identification Number | 02329271 |
Brand name | OCTREOSCAN |
Common or Proper name | Kit for the preparation of Indium In 111 Pentetreotide |
Company Name | CURIUM CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PENTETREOTIDE INDIUM IN 111 CHLORIDE |
Strength(s) | 10MCG 111MBq |
Dosage form(s) | POWDER FOR SOLUTION KIT SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 ml |
ATC code | V09IB |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2024-03-18 |
Estimated end date | 2024-03-31 |
Actual end date | 2024-04-08 |
Shortage status | Resolved |
Updated date | 2024-04-09 |
Company comments | The most recent lot of Indium In-111 raw material used in the production of Octreoscan did not meet quality specifications. As a result, product will not be available for shipment Sunday, Mar 17 and Monday, Mar 18, & Mar 24 and Mar 25. The next lot is scheduled to release Sunday, Mar 31. We apologize for any inconvenience caused by this issue. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2572 BOUL. DANIEL-JOHNSON LAVAL, QUEBEC CANADA H7T 2R3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-04-09 | French | Compare |
v6 | 2024-04-09 | English | Compare |
v5 | 2024-03-25 | French | Compare |
v4 | 2024-03-25 | English | Compare |
v3 | 2024-03-19 | English | Compare |
v2 | 2024-03-18 | French | Compare |
v1 | 2024-03-18 | English | Compare |
Showing 1 to 7 of 7